BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24989615)

  • 1. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
    Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
    BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
    Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
    Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
    Mavrodi A; Aletras V
    Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
    Song HJ; Lee EK
    Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
    Nimdet K; Ngorsuraches S
    BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT; Tsevat J; Lave JR; Roberts MS
    Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
    Byrne MM; O'malley K; Suarez-Almazor ME
    Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
    Nielsen JS; Gyrd-Hansen D; Kjaer T
    Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Gaining or losing": The importance of the perspective in primary care health services valuation.
    Martín-Fernández J; Ariza-Cardiel G; Peña-Longobardo LM; Polentinos-Castro E; Oliva-Moreno J; Gil-Lacruz AI; Medina-Palomino H; Del Cura-González I
    PLoS One; 2017; 12(12):e0188969. PubMed ID: 29206847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity.
    Mavrodi A; Aletras V; Spanou A; Niakas D
    Pharmacoecon Open; 2017 Dec; 1(4):291-300. PubMed ID: 29441505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to pay for a QALY.
    Gyrd-Hansen D
    Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating a WTP-based value of a QALY: the 'chained' approach.
    Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
    Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay for QALY: perspectives and contexts in Japan.
    Igarashi A; Goto R; Yoneyama-Hirozane M
    J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
    [No Abstract]   [Full Text] [Related]  

  • 15. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
    Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
    PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between willingness to pay and willingness to accept for visits by a family physician: a contingent valuation study.
    Martín-Fernández J; del Cura-González MI; Gómez-Gascón T; Oliva-Moreno J; Domínguez-Bidagor J; Beamud-Lagos M; Pérez-Rivas FJ
    BMC Public Health; 2010 May; 10():236. PubMed ID: 20459714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to pay for a quality-adjusted life year among advanced non-small cell lung cancer patients in Viet Nam, 2018.
    Ha TV; Hoang MV; Vu MQ; Hoang NT; Khuong LQ; Vu AN; Pham PC; Vu CV; Duong LH
    Medicine (Baltimore); 2020 Feb; 99(9):e19379. PubMed ID: 32118784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios.
    Isah A; Adibe MO; Abba A; Dim OF; Ekwuofu AA; Ma'aji HU; Ukwe CV; Udeogaranya PO; Okonta MJ
    J Clin Pharm Ther; 2021 Dec; 46(6):1695-1705. PubMed ID: 34448210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating a constant WTP for a QALY-a mission impossible?
    Sund B; Svensson M
    Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.